P2RX7 and psoriasis: In this latter case, they induced a stable resolution of severe psoriasis, opening the concrete possibility of targeting extracellular ADO degradative pathways, as well as P2X7 receptor as new therapeutic options to treat psoriasis at its onset and possibly recurrence [121,122].